Rezultati pretrage - Max Johnson
- Prikaz rezultata 1 – 7 od 7
-
1
Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease od James Brett Case, Rita E. Chen, Longxing Cao, Baoling Ying, Emma S. Winkler, Max Johnson, Inna Goreshnik, Minh N. Pham, Swathi Shrihari, Natasha M. Kafai, Adam L. Bailey, Xuping Xie, Pei‐Yong Shi, Rashmi Ravichandran, Lauren Carter, Lance Stewart, David Baker, Michael Diamond
Izdano 2021Artigo -
2
Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design od Daniel Ellis, Natalie Brunette, Katharine H. D. Crawford, Alexandra C. Walls, Minh N. Pham, Chengbo Chen, Karla−Luise Herpoldt, Brooke Fiala, Michael Murphy, Deleah Pettie, John C. Kraft, Keara D. Malone, Mary Jane Navarro, Cassandra Ogohara, Elizabeth Kepl, Rashmi Ravichandran, Claire Sydeman, Maggie Ahlrichs, Max Johnson, Alyssa Blackstone, Lauren Carter, Tyler N. Starr, Allison J. Greaney, Kelly K. Lee, David Veesler, Jesse D. Bloom, Neil P. King
Izdano 2021Artigo -
3
Antigen- and scaffold-specific antibody responses to protein nanoparticle immunogens od John C. Kraft, Minh N. Pham, Laila Shehata, Mitch Brinkkemper, Seyhan Boyoglu-Barnum, Kaitlin R. Sprouse, Alexandra C. Walls, Suna Cheng, Michael Murphy, Deleah Pettie, Maggie Ahlrichs, Claire Sydeman, Max Johnson, Alyssa Blackstone, Daniel Ellis, Rashmi Ravichandran, Brooke Fiala, Samuel Wrenn, Marcos C. Miranda, Kwinten Sliepen, Philip J. M. Brouwer, Aleksandar Antanasijevic, David Veesler, Andrew B. Ward, Masaru Kanekiyo, Marion Pepper, Rogier W. Sanders, Neil P. King
Izdano 2022Artigo -
4
Vaccination with a structure-based stabilized version of malarial antigen Pfs48/45 elicits ultra-potent transmission-blocking antibody responses od Brandon McLeod, Moustafa T. Mabrouk, Kazutoyo Miura, Rashmi Ravichandran, Sally Kephart, Sophia Hailemariam, Thao Pham, Anthony Semesi, Iga Kucharska, Prasun Kundu, Wei‐Chiao Huang, Max Johnson, Alyssa Blackstone, Deleah Pettie, Michael Murphy, John C. Kraft, Elizabeth M. Leaf, Yang Jiao, Marga van de Vegte‐Bolmer, Geert‐Jan van Gemert, Jordache Ramjith, C. Richter King, Randall S. MacGill, Yimin Wu, Kelly K. Lee, Matthijs M. Jore, Neil P. King, Jonathan F. Lovell, Jean‐Philippe Julien
Izdano 2022Artigo -
5
De novo design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8 od Anindya Roy, Lei Shi, Ashley Chang, Xianchi Dong, Andres Fernandez, John C. Kraft, Jing Li, Viet Q. Le, Rebecca Viazzo Winegar, Gerald Maxwell Cherf, Dean Slocum, P. Daniel Poulson, Garrett E. Casper, Mary L. Vallecillo-Zúniga, Jonard Corpuz Valdoz, Marcos C. Miranda, Hua Bai, Yakov Kipnis, Audrey Olshefsky, Tanu Priya, Lauren Carter, Rashmi Ravichandran, Cameron M. Chow, Max Johnson, Suna Cheng, McKaela Smith, Catherine Overed-Sayer, Donna K. Finch, David C. Lowe, Asim K. Bera, Gustavo Matute‐Bello, Timothy P. Birkland, Frank DiMaio, Ganesh Raghu, Jennifer R. Cochran, Lance Stewart, Melody G. Campbell, Pam M. Van Ry, Timothy A. Springer, David Baker
Izdano 2023Artigo -
6
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines od Alexandra C. Walls, Marcos C. Miranda, Alexandra Schäfer, Minh N. Pham, Allison J. Greaney, Prabhu S. Arunachalam, Mary-Jane Navarro, M. Alejandra Tortorici, Kenneth A. Rogers, Megan A. O’Connor, Lisa Shirreff, Douglas E. Ferrell, John E. Bowen, Natalie Brunette, Elizabeth Kepl, Samantha K. Zepeda, Tyler N. Starr, Ching‐Lin Hsieh, Brooke Fiala, Samuel Wrenn, Deleah Pettie, Claire Sydeman, Kaitlin R. Sprouse, Max Johnson, Alyssa Blackstone, Rashmi Ravichandran, Cassandra Ogohara, Lauren Carter, Sasha W. Tilles, Rino Rappuoli, Sarah R. Leist, David R. Martinez, Matthew Clark, Roland Tisch, Derek T. O’Hagan, Robbert van der Most, Wesley C. Van Voorhis, Davide Corti, Jason S. McLellan, Harry Kleanthous, Timothy P. Sheahan, Kelly D. Smith, Deborah H. Fuller, François Villinger, Jesse D. Bloom, Bali Pulendran, Ralph S. Baric, Neil P. King, David Veesler
Izdano 2021Artigo -
7
Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice od Andrew C. Hunt, James Brett Case, Young‐Jun Park, Longxing Cao, Kejia Wu, Alexandra C. Walls, Zhuoming Liu, John E. Bowen, Hsien‐Wei Yeh, Shally Saini, Louisa Helms, Yan Ting Zhao, Tien-Ying Hsiang, Tyler N. Starr, Inna Goreshnik, Lisa Kozodoy, Lauren Carter, Rashmi Ravichandran, Lydia B. Green, Wadim L. Matochko, Christy A. Thomson, Bastian Vögeli, Antje Krüger, Laura A. VanBlargan, Rita E. Chen, Baoling Ying, Adam L. Bailey, Natasha M. Kafai, Scott E. Boyken, Ajasja Ljubetič, Natasha I. Edman, George Ueda, Cameron M. Chow, Max Johnson, Amin Addetia, Mary-Jane Navarro, Nuttada Panpradist, Michael Gale, Benjamin Freedman, Jesse D. Bloom, Hannele Ruohola‐Baker, Sean P. J. Whelan, Lance Stewart, Michael Diamond, David Veesler, Michael C. Jewett, David Baker
Izdano 2022Artigo
Alati za pretragu:
Povezani predmeti
Biology
Virology
Antibody
Immunology
Medicine
Coronavirus disease 2019 (COVID-19)
Disease
Genetics
Infectious disease (medical specialty)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Antigen
Computational biology
Pathology
Receptor
Chemistry
Immune system
Monoclonal antibody
Virus
2019-20 coronavirus outbreak
Antibody response
Antigenicity
Biochemistry
Biomedical engineering
Biophysics
Blocking (statistics)
Blocking antibody
Cancer research
Cell
Cell biology
Coronavirus